The legacy of Viagra and its impact on the pharmaceutical sector presents a challenging question regarding its continued appeal as an investment. Initially a blockbuster success, generating huge sums , generic competition has significantly eroded financial returns. While established pharmaceutical firms hold patents on related therapies and investi

The performance of companies tied to iconic drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial wealth , the expiry in key markets has introduced considerable risk . Investors are now facing the impact of rival medications , reduced revenu